CAS 917910-45-3

2-{3-[3-(5-hydroxypyridin-2-yl)-1,2,4-oxadiazol-5-yl]-2,2-dimethylpropanamido}cyclohex-1-ene-1-carboxylic acid

CAS : 917910-45-3

Formule : C₁₉H₂₂N₄O₅

Degré de pureté : 98%

Masse moléculaire : 386.4018

Ref: IN-DA00GU4E

MK-6892

CAS : 917910-45-3

MK-6892

Degré de pureté : ≥98%

Masse moléculaire : 386.4g/mol

Ref: 54-BUP08822

MK-6892

CAS : 917910-45-3

MK-6892 is a selective and full agonist for the high-affinity nicotinic acid receptor GPR109A (Ki: 4 nM; GTPγS EC50: 16 nM).

Formule : C₁₉H₂₂N₄O₅

Degré de pureté : 99.01% - 99.67%

Couleur et forme : Solid

Masse moléculaire : 386.4

Ref: TM-TQ0108

MK-6892

CAS : 917910-45-3

MK-6892 is a β-lactamase inhibitor that has been shown to be effective in the treatment of skin infections. It has been shown to inhibit transduction pathways by binding to β-lactamase and preventing it from hydrolyzing β-lactams, thereby increasing the activity of β-lactams. MK-6892 also inhibits receptor activities and kinetics, making it an excellent candidate for use in diagnosis. The drug has been shown to have affinity for lipoproteins and dyslipidemia, as well as ancillary effects on body fluid composition.

Formule : C₁₉H₂₂N₄O₅

Degré de pureté : Min. 95%

Masse moléculaire : 386.4 g/mol

Ref: 3D-SLB91045